Weiss Multi Strategy Advisers LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $194,835 - $354,826	-7,011 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $35,776 - $63,182	903 Added 14.78%	7,011 $322,000
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $177,813 - $252,563	-3,061 Reduced 33.38%	6,108 $405,000
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $535,286 - $778,998	9,169 New	9,169 $572,000
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $441,617 - $860,358	-10,078 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $168,275 - $259,785	5,067 Added 101.12%	10,078 $434,000
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $130,887 - $216,825	5,011 New	5,011 $216,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.